Upload Avatar (500 x 500)
Songping Xie
songping0428@126.com
Chinese, English
Hubei
Wuhan University
Medical School
  • 2012-09 to 2016-12, Wuhan University, Doctorate in Cardiothoracic Surgery
  • 2007-09 to 2009-06, Wuhan University, Master's in Thoracic Surgery
  • 2002-09 to 2007-06, Wuhan University, Bachelor in Clinical Medicine
  • Published 58 papers, including 20 SCI-indexed articles
  • 2022/11 to present, Wuhan University, Renmin Hospital, Chief Physician
  • 2019/11 to present, Wuhan University, Renmin Hospital, Associate Professor
  • 2017/12 to 2022/11, Wuhan University, Renmin Hospital, Deputy Chief Physician
  • 2012/06 to 2017/11, Wuhan University, Renmin Hospital, Attending Physician
  • 2009/09 to 2012/05, Wuhan University, Renmin Hospital, Resident Physician
  • Second Class Prize for Scientific and Technological Achievement Award (Hubei Province)
  • First Class Prize of The Provincial Scientific and Technological Progress Award
CXCR4
Acute lung injury
Surgical treatment of thoracic cancer
  • MEGF6 prevents sepsis-induced acute lung injury in mice, Hui Liang, Gaoli Liu, Wenhui Zeng, Qinglu Fan, Zhihao Nie, Haifeng Hu, Renquan Zhang, Songping Xie, 2023
  • Nesfatin-1, a novel energy-regulating peptide, alleviates pulmonary fibrosis by blocking TGF-β1/Smad pathway in an AMPKα-dependent manner, Zhang RenQuan, Liang Hui, Liu GaoLi, Jiang WanLi, Tang Zheng, Fan QingLu, Nie ZhiHao, Hu HaiFeng, Kang GanJun, Xie SongPing, 2023
  • TTYH3, a potential prognosis biomarker associated with immune infiltration and immunotherapy response in lung cancer, Wei ZiMeng, Zeng XinRuo, Lei YuFei, He HengJing, Jamal Muhammad, Zhang ChengJie, Tan HaiYan, Xie SongPing, Zhang QiuPing, 2022
Cxcr4 Lung Injury Thoracic Surgery Surgical Treatment Cancer Therapy Minimally Invasive Surgery Esophageal Surgery Lung Cancer Esophageal Cancer Clinical Research

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.